HC Wainwright & Co. Maintains Buy on Acurx Pharmaceuticals, Lowers Price Target to $11
HC Wainwright & Co. analyst Matthew Keller maintains Acurx Pharmaceuticals (NASDAQ:ACXP) with a Buy and lowers the price target from $31 to $11.

Last updated: 2026-11-15 15:18:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Acurx Pharmaceuticals, Inc. (ACXP) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.96, with a market capitalization of $5.25M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.92 to $7.54. This page covers its latest market performance, valuation, price trends and company information.
$5.25M | |
$1.04 | |
$1.09 | |
$0.94 | |
$0.99 | |
208.15K | |
100.56K | |
-- | |
$7.54 | |
$0.92 | |
-- | |
-- |
Acurx Pharmaceuticals, Inc. (ACXP) last closed at $0.96 as of 2026-11-14 00:49:00, down 3.56% ($0.04) from the previous close of $0.99.
During the latest regular trading session, ACXP traded between $0.94 and $1.09, with a volume of 208.15K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Acurx Pharmaceuticals, Inc. (ACXP) moved from $0.95 to $0.96, representing a gain of 1.62% ($0.02).
The stock traded between $0.92 and $1.12 during the period. The latest price is near the lower end of the 7-day range, indicating moderate upward.
The average daily volume was 140.04 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0.6%
ACXP is currently trading at $0.96, placing it 0.6% of the way from its 52-week low of $0.92 to its 52-week high of $7.54. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 4 |
| Exchange | NASDAQ |
| Company Website |
Latest news related to Acurx Pharmaceuticals, Inc. and ACXP stock.
HC Wainwright & Co. analyst Matthew Keller maintains Acurx Pharmaceuticals (NASDAQ:ACXP) with a Buy and lowers the price target from $31 to $11.
Acurx Pharmaceuticals (NASDAQ:ACXP) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by
Acurx Pharmaceuticals (NASDAQ:ACXP) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $(0.39) by 25.64 percent. This is a 60.16 percent increase over losses of $(1.23) per
Eligible investors can buy real shares of Acurx Pharmaceuticals, Inc. (ACXP) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to ACXP, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between ACXP shares and USD.
ACXP Shares to USD
1.00 ACXP shares = 0.961 USD
Calculations are estimates based on the latest available price and are for reference only.